Major US Firms Disclose $6.3 Million in Q1 2026 Lobbying Expenditures

Major US corporations have disclosed significant lobbying expenditures for the first quarter of 2026, with three leading entities spending a combined total of over $6.3 million. UnitedHealth Group Inc. led the group with $2,670,000 directed toward healthcare data privacy and drug pricing legislation. ConocoPhillips disclosed $1,950,000 in spending aimed at environmental regulations and oil and gas permitting processes. Meanwhile, Caterpillar Inc. allocated $1,680,000 to influence policy regarding emissions, tax issues, and international trade. These disclosures highlight the strategic efforts of major firms to mitigate regulatory risks and protect operational interests within the US Congress. While the figures are substantial, analysts view these expenditures as routine corporate governance activities rather than fundamental shifts in market position. However, they provide critical insight into the specific regulatory challenges facing the healthcare, energy, and industrial sectors.